Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: Journal of Medical Internet Research (no longer under consideration since Jan 19, 2022)

Date Submitted: Nov 15, 2021

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Digital health innovations in China in response to Covid-19 pandemic: benefits, challenges and future trends

  • Xiaoting Sun; 
  • Yuhong Yang; 
  • Jialin Charlie Zheng

ABSTRACT

In response to the Covid-19 pandemic, China has made tremendous efforts in developing digital innovations such as health QR code, digital vaccine chains and Internet hospitals in helping with disease surveillance, vaccination, and health service delivery. Our manuscript briefly summarized the benefits, challenges, and future trends of these digital health innovations, hoping to call for further discussion from the international audience.


 Citation

Please cite as:

Sun X, Yang Y, Zheng JC

Digital health innovations in China in response to Covid-19 pandemic: benefits, challenges and future trends

JMIR Preprints. 15/11/2021:34976

DOI: 10.2196/preprints.34976

URL: https://preprints.jmir.org/preprint/34976

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.